Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

A first-of-its-kind oral drug boosts muscle metabolism to improve blood sugar and body composition is now headed into larger ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past? A healthy ...

Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...

Eli Lilly’s new oral GLP-1 drug, orforglipron, is shaping up to be a major development in obesity treatment, showing nearly ...

A new CNN story scapegoats alcohol for flight incidents while ignoring statistics on both unruly incidents and actual booze ...

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

ZDNET experts put every product through rigorous testing and research to curate the best options for you. If you buy through our links, we may earn a commission. Learn Our Process 'ZDNET Recommends': ...

LONDON, Nov 12 (Reuters) - Generic drugmaker Sandoz (SDZ.S), opens new tab expects unbranded versions of Novo Nordisk's (NOVOb.CO), opens new tab blockbuster diabetes drug Ozempic to launch in Canada ...

GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study. Patients on the medications had less than half the mortality rate of ...

New reviews reveal that GLP-1 drugs such as tirzepatide, semaglutide, and liraglutide can lead to significant, clinically meaningful weight loss. Yet, questions linger over their long-term safety, ...

NEW DELHI — When the weight loss drug Mounjaro came on the market in India earlier this year, Shyamanthak Kiran was one of the first patients to try it. Kiran, a 27-year-old financial trader who has ...